INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Rhea-AI Summary

INOVIO (NASDAQ:INO), a biotechnology company specializing in DNA medicines for HPV-associated diseases, cancer, and infectious diseases, will participate in the H.C. Wainwright 27th Annual Global Investment Conference.

The company will provide a pre-recorded presentation available on demand starting September 5, 2025, at 7:00 AM ET. INOVIO's management team will conduct in-person one-on-one meetings with investors during the conference. The webcast will remain accessible for 90 days through the provided link and INOVIO's Investor Relations Events page.

News Market Reaction – INO

-0.51%

-0.51% Session close to close

In the Aug 25 session, INO declined 0.51%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., Aug. 25, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that a pre-recorded presentation from the Company will be available on demand as a part of the H.C. Wainwright 27th Annual Global Investment Conference in New York. During the conference, members of INOVIO's management team will also be conducting in-person one-on-one meetings with investors.

H.C. Wainwright 27th Annual Global Investment Conference
Presentation available: Beginning Friday, September 5, 2025, 7:00AM ET
Format: Pre-recorded webcast
Link: https://journey.ct.events/view/c0cc4d12-f619-4d58-878f-4ee305e4f2c2

The webcast will be available for 90 days at the link above or on the INOVIO Investor Relations Events page: https://ir.inovio.com/events-and-presentations/default.aspx. 

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. 

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, 443-213-0505, investor.relations@inovio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference-302536840.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When is INOVIO's presentation at the H.C. Wainwright Conference 2025?

INOVIO's pre-recorded presentation will be available on demand starting September 5, 2025, at 7:00 AM ET.

How long will INOVIO's H.C. Wainwright Conference presentation be available?

The webcast will be available for 90 days through both the conference link and INOVIO's Investor Relations Events page.

What type of meetings will INOVIO conduct at the H.C. Wainwright Conference?

INOVIO's management team will conduct in-person one-on-one meetings with investors during the conference.

Where can investors access INOVIO's H.C. Wainwright Conference presentation?

Investors can access the presentation through the conference link or INOVIO's Investor Relations Events page at ir.inovio.com.